Cigna Group: Form 10-Q for the period ended Jun 30, 2023
Filed with the SEC on Aug 3, 2023 and accepted by EDGAR at Aug 3, 2023, 10:36 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-01 to 2023-06-30 | $48.59bn | us-gaap:Revenues |
| Revenue | 6 months2023-01-01 to 2023-06-30 | $95.10bn | us-gaap:Revenues |
| Cost of revenue | 3 months2023-04-01 to 2023-06-30 | $33.44bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-01-01 to 2023-06-30 | $64.90bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2023-04-01 to 2023-06-30 | $3.43bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-01-01 to 2023-06-30 | $6.97bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-04-01 to 2023-06-30 | $2.22bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-01 to 2023-06-30 | $4.24bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-04-01 to 2023-06-30 | $374.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-01-01 to 2023-06-30 | $669.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-01 to 2023-06-30 | $1.51bn | us-gaap:ProfitLoss |
| Net income | 6 months2023-01-01 to 2023-06-30 | $2.82bn | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2023-04-01 to 2023-06-30 | $4.92 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-06-30 | $9.15 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-01 to 2023-06-30 | $4.96 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-06-30 | $9.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-01 to 2023-06-30 | 296,879,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-06-30 | 297,936,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-06-30 | $7.52bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 6 months2023-01-01 to 2023-06-30 | $730.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2023-01-01 to 2023-06-30 | $1.12bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-06-30 | $9.59bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-06-30 | $34.71bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-06-30 | $150.05bn | us-gaap:Assets |
| Current liabilities | At period end2023-06-30 | $47.34bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-06-30 | $104.53bn | us-gaap:Liabilities |
| Current portion of debt | At period end2023-06-30 | $4.62bn | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2023-06-30 | $200.0m | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2023-06-30 | $45.45bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001739940-23-000020. Last ingested by Listed: Nov 5, 2026, 13:13 ET. Listed shows no prices and gives no investment advice.